BECTON, DICKINSON AND COMPANY Equity Securities, FV-NI, Gain (Loss)
BECTON, DICKINSON AND COMPANY (BDX) reported Equity Securities, FV-NI, Gain (Loss) of -$5.00 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2025-11-25
- BECTON, DICKINSON AND COMPANY equity securities, fv-ni, gain (loss) for fiscal 2025 was -$5.00M, a 200.00% decline from fiscal 2024.
- BECTON, DICKINSON AND COMPANY equity securities, fv-ni, gain (loss) for fiscal 2024 was $5.00M.
- BECTON, DICKINSON AND COMPANY equity securities, fv-ni, gain (loss) for fiscal 2023 was -$3.00M.
- BECTON, DICKINSON AND COMPANY equity securities, fv-ni, gain (loss) for fiscal 2022 was -$35.00M, a 161.40% decline from fiscal 2021.
| Period end | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|
| 2025-09-30 | -$5.00M 10-K · filed 2025-11-25 |
| 2024-09-30 | $5.00M 10-K · filed 2025-11-25 |
| 2023-09-30 | -$3.00M 10-K · filed 2025-11-25 |
| 2022-09-30 | -$35.00M 10-K · filed 2024-11-27 |
| 2021-09-30 | $57.00M 10-K · filed 2023-11-21 |
| 2020-09-30 | $13.00M 10-K · filed 2022-11-22 |
| 2019-09-30 | $18.00M 10-K · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |